Organon – New Company Focused On Women’s Health That’s Listening To Women
Dr. Sandy Milligan, Head of Research & Development at Organon, discusses the current state of women’s health and the company’s goal to redefine it by putting all women at the center of everything they do and by listening to her to better meet her needs — big or small.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Healthcare?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
As the head of research and development for Organon, Sandy Milligan is leading the advancement of a differentiated portfolio of medicines and solutions to help women and all patients live a better and healthier every day. In her role, Sandy oversees the organization’s scientific, medical and regulatory capabilities in support of its diverse portfolio and long-term vision.Before joining Organon, Sandy served as Merck’s senior vice president and head of global regulatory affairs and clinical safety. Previously, she served as vice president of product development regulatory for Genentech, and from 2002 to 2012, she was at Amgen in positions of increasing responsibility across legal and regulatory affairs functions. Sandy served in the U.S. Army Medical Corps from 1987 to 1994.Sandy was on the Board of Directors of the Drug Information Association (DIA) from 2011-2017, including serving as chair, and is now a DIA fellow. With a deep commitment to fostering diverse leadership, Sandy has served as co-sponsor of the Merck women’s leadership program.She is a graduate of George Washington University School of Medicine and received a J.D. from the Georgetown University Law Center.
Listen on Soundcloud.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
